NeuroSigmahas received FDA clearance for its forehead patch which stimulates the trigeminal nerve during sleep to treat ADHD. The device won CE Mark approval in Europe in 2015. The approval was based on studyof 62 subjects. Over four weeks, those...
NeuroSigmahas received FDA clearance for its forehead patch which stimulates the trigeminal nerve during sleep to treat ADHD. The device won CE Mark approval in Europe in 2015. The approval was based on studyof 62 subjects. Over four weeks, those...